Prestige Consumer Healthcare Inc. revised earnings guidance for the year of Fiscal 2024. For the year, company expects Diluted E.P.S. of approximately $4.33 compared to $4.27 to $4.32 prior guidance and expects revenue of $1,135 million to $1,140 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.74 USD | +1.80% | +2.78% | +17.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.18% | 3.5B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- PBH Stock
- News Prestige Consumer Healthcare Inc.
- Prestige Consumer Healthcare Inc. Revises Earnings Guidance for the Year of Fiscal 2024